• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Lasa Supergenerics Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting

    13-02-2026 | 03:42 pm

    Lasa Supergenerics' board approved standalone Q3 FY26 & year-to-date results. Auditors highlighted severe concerns: an uninsured fire in May 2025 halted all production, causing Rs 12.74 Cr inventory & Rs 7.00 Cr PPE losses. Company faces going concern issues.

    No comments yet. Be the first to comment!

    All announcements from Lasa Supergenerics Limited